We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Éclat Wants FDA to Pull ‘Unapproved’ Injectables
Éclat Wants FDA to Pull ‘Unapproved’ Injectables
September 13, 2013
Éclat Pharmaceuticals is calling on the FDA to stop five of its competitors from selling certain injectables that the specialty drugmaker claims are unsafe and unapproved drugs.